Last updated at 29 Jun 2024 12:03 AM
Director
DIN: 03267801
Vittaladas Vedavyasa Bhat is currently associated with 2 companies in various capacities such as Director and Additional Director. They serve as a Director at FORTUNA PHARMA LABORATORIES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 03267801.Vittaladas Vedavyasa Bhat is currently involved in 2 different roles. Their most recent position is with BLUTE TECHNOLOGIES PRIVATE LIMITED as a Additional Director. The first company Vittaladas Vedavyasa Bhat was appointed to as a director was FORTUNA PHARMA LABORATORIES PRIVATE LIMITED. Vittaladas Vedavyasa Bhat is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Vittaladas Vedavyasa Bhat is currently associated with 2 companies in various capacities such as Director and Additional Director. They serve as a Director at FORTUNA PHARMA LABORATORIES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 03267801.Vittaladas Vedavyasa Bhat is currently involved in 2 different roles. Their most recent position is with BLUTE TECHNOLOGIES PRIVATE LIMITED as a Additional Director. The first company Vittaladas Vedavyasa Bhat was appointed to as a director was FORTUNA PHARMA LABORATORIES PRIVATE LIMITED. Vittaladas Vedavyasa Bhat is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
3 Years 1y 6m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| FORTUNA PHARMA LABORATORIES PRIVATE LIMITED | Director | 09-Feb-2011 |
| BLUTE TECHNOLOGIES PRIVATE LIMITED | Additional Director | 02-Sep-2020 |